Pseudoginsenoside Rh2

Pseudoginsenoside Rh2
Product Name Pseudoginsenoside Rh2
CAS No.: 1370264-16-6
Catalog No.: CFN93178
Molecular Formula: C36H62O8
Molecular Weight: 622.88 g/mol
Purity: >=98%
Type of Compound: Triterpenoids
Physical Desc.: Powder
Targets: Raf | ERK | p53 | Bcl-2/Bax | Caspase | PARP
Source: The roots of Panax ginseng C. A. Mey.
Solvent: DMSO, Pyridine, Methanol, Ethanol, etc.
Price:
Pseudoginsenoside Rh2 has cytotoxicity, it induces mitochondrial apoptosis in A549 cells and is responsible for excessive activation of the Ras/Raf/ERK/p53 pathway. (20Z) -Pseudoginsenoside Rh2 and (20E)-Pseudoginsenoside Rh2 have antioxidative activity.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Front Endocrinol (Lausanne).2020, 11:568436.
  • Chem Pharm Bull (Tokyo).2017, 65(9):826-832
  • Nat Prod Sci.2018, 24(3):206
  • Cells.2022, 11(6):931.
  • BMC Complement Altern Med.2017, 17(1):393
  • Enzyme Microb Technol.2022, 161:110111.
  • Molecules.2020, 25(17):3783.
  • Chemistr of plant2016, 2016021195
  • Food Research International2020, 108987
  • Neurochem Res.2021, s11064-021-03449-0
  • Methylophiopogonanone B

    Catalog No: CFN98596
    CAS No: 74805-91-7
    Price: $268/20mg
    N-p-Coumaroyloctopamine

    Catalog No: CFN97706
    CAS No: 66648-45-1
    Price: $218/10mg
    Stigmasterol glucoside

    Catalog No: CFN98000
    CAS No: 19716-26-8
    Price: $368/5mg
    Epiberberine

    Catalog No: CFN98564
    CAS No: 6873-09-2
    Price: $168/20mg
    Luteolin 7-rutinoside

    Catalog No: CFN93556
    CAS No: 20633-84-5
    Price: $218/20mg
    Exp Ther Med. 2018 Jun;15(6):4916-4924.
    Pseudo-Ginsenoside Rh2 induces A549 cells apoptosis via the Ras/Raf/ERK/p53 pathway.[Pubmed: 29805515]
    Ginsenoside Rh2, a major effective constituent of ginseng, has been suggested to have a pro-apoptotic effect in a variety of cancer cells. Pseudoginsenside Rh2 (pseudo-G-Rh2) is a novel derivative of ginsenoside Rh2. The aim of the present study was to evaluate the effect of pseudo-G-Rh2 on the apoptosis of lung adenocarcinoma A549 cells.
    METHODS AND RESULTS:
    The cytotoxicity of pseudo-G-Rh2 on A549 cells was evaluated using an MTT assay. Apoptosis was detected using DAPI staining and flow cytometry. The expression of apoptosis associated proteins was identified by western blot analysis. The results demonstrated that pseudo-G-Rh2 inhibits the proliferation of A549 cells in a dose-dependent manner. DAPI staining revealed topical morphological changes in apoptotic bodies following pseudo-G-Rh2 treatment. Flow cytometric analysis revealed that the percentage of Annexin V-fluorescein isothiocyanate-positive cells, which are apoptotic, increased with pseudo-G-Rh2 treatment in a dose-dependent manner. Furthermore, treatment with pseudo-G-Rh2 increased the level of reactive oxygen species in A549 cells as well as the activation of caspase-9, caspase-3 and poly ADP-ribose polymerase. Pseudo-G-Rh2 treatment was observed to induce mitochondrial membrane potential loss. Furthermore, the results of western blotting revealed that B-cell lymphoma 2 (Bcl-2) expression was significantly decreased while Bcl-2-associated X protein expression was significantly upregulated in A549 cells with pseudo-G-Rh2 treatment. Pseudo-G-Rh2-induced apoptosis was accompanied by sustained phosphorylation of Ras, Raf, extracellular signal-regulated kinase (ERK) and p53.
    CONCLUSIONS:
    In conclusion, the results of the present study suggest that pseudo-G-Rh2 induces mitochondrial apoptosis in A549 cells and is responsible for excessive activation of the Ras/Raf/ERK/p53 pathway.
    Chem Pharm Bull (Tokyo). 2018 May 1;66(5):535-540.
    Semi-synthesis of Twelve Known 20Z/E Pseudo-Ginsenosides and Their Comparative Study of Antioxidative Activity in Free Radical Induced Hemolysis of Rabbit Erythrocytes.[Pubmed: 29515052]

    METHODS AND RESULTS:
    Twelve pseudo-ginsenosides were synthesized under a mild condition, via a simple three-step called acetylation, elimination-addition and saponification. The inhibitory effects of these twelve pseudo-ginsenosides were screened on the hemolysis of rabbit erythrocytes caused by 2,2'-azobis (2-amidinopropane hydrochloride) (AAPH).It was found that the IC50 values followed the sequence of (20Z) pseudo-protopanaxatriol (pseudo-PPT)<(20Z) pseudo-protopanaxadiol (pseudo-PPD)<(20Z) pseudo-Rh2(Pseudoginsenoside Rh2)<(20E) pseudo-PPT<(20E) pseudo-PPD<(20E) pseudo-Rh2(Pseudoginsenoside Rh2)<(20Z) pseudo-Rg2<(20E) pseudo-Rg2 CONCLUSIONS:
    These compounds can be divided into three groups: accelerate the hemolysis group (7, 8), weak group (2, 11, 12) and strong group (others). Moreover, we also find that most of the Z configuration has better antioxidative activity than E configuration and the number and type of sugar moieties to the ring of triterpene dammarane influence the antioxidative activity.
    Carasinol D

    Catalog No: CFN95044
    CAS No: 1072797-66-0
    Price: $333/5mg
    Carasiphenol C

    Catalog No: CFN95045
    CAS No: 868168-04-1
    Price: $368/5mg
    ent-16beta,17-dihydroxy-9(11)-kauren-19-oic acid

    Catalog No: CFN95172
    CAS No: 55483-24-4
    Price: $318/10mg
    Arisanschinin E

    Catalog No: CFN95221
    CAS No: 1333378-33-8
    Price: Inquiry(manager@chemfaces.com)
    9-Octadecenedioic acid

    Catalog No: CFN95301
    CAS No: 4494-16-0
    Price: $218/5mg
    Euphorbia factor L22

    Catalog No: CFN95338
    CAS No: 1613700-09-6
    Price: $413/5mg
    ZP-amide C

    Catalog No: CFN95362
    CAS No: 412316-38-2
    Price: $318/5mg
    Narirutin 4'-glucoside

    Catalog No: CFN95421
    CAS No: 17257-22-6
    Price: $318/10mg
    Ganoweberianic acid E

    Catalog No: CFN95504
    CAS No: 1309931-90-5
    Price: $413/5mg
    New compound 20

    Catalog No: CFN95545
    CAS No: N/A
    Price: $413/5mg